Northpointe Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $3.77M | Buy |
74,424
+59,058
| +384% | +$2.99M | 1.46% | 23 |
|
2019
Q2 | $697K | Sell |
15,366
-28,958
| -65% | -$1.31M | 0.22% | 82 |
|
2019
Q1 | $2.12M | Sell |
44,324
-28,823
| -39% | -$1.38M | 0.67% | 68 |
|
2018
Q4 | $3.8M | Buy |
+73,147
| New | +$3.8M | 0.86% | 30 |
|
2017
Q3 | – | Sell |
-37,626
| Closed | -$2.1M | – | 173 |
|
2017
Q2 | $2.1M | Buy |
+37,626
| New | +$2.1M | 0.22% | 153 |
|
2016
Q1 | – | Sell |
-47,471
| Closed | -$2.81M | – | 239 |
|
2015
Q4 | $2.81M | Hold |
47,471
| – | – | 0.37% | 105 |
|
2015
Q3 | $2.81M | Buy |
47,471
+4,836
| +11% | +$286K | 0.37% | 106 |
|
2015
Q2 | $2.84M | Buy |
+42,635
| New | +$2.84M | 0.33% | 102 |
|
2014
Q1 | – | Sell |
-17,870
| Closed | -$951K | – | 238 |
|
2013
Q4 | $951K | Buy |
+17,870
| New | +$951K | 0.08% | 207 |
|